Terminology [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2017-02-18 16:27  – Posting: # 17086
Views: 10,557

Hi BE-proff,

» Rather risky - such methods must be present in our guides otherwise our designs will be rejected...

“Type 1” or “Type 2” was my proposal to introduce an unambiguous terminology. Get the paper at sci-hub. ;-)
On the contrary the Russian guideline (copypasted from the EMA’s) is ambigous (“For example, using 94.12% confidence intervals […] would be acceptable, but there are many acceptable alternatives and the choice of how much alpha to spend at the interim analysis is at the company's discretion”).

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
20,798 posts in 4,354 threads, 1,445 registered users;
online 8 (0 registered, 8 guests [including 6 identified bots]).
Forum time: 01:40 CEST (Europe/Vienna)

If a man will begin with certainties, he will end in doubts;
but if he will be content to begin with doubts,
he will end in certainties.    Francis Bacon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz